Literature DB >> 18286675

Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.

Anupender Singh Sidhu, George Triadafilopoulos.   

Abstract

The junction between the esophagus and the stomach is a specialized region, composed of lower esophageal sphincter (LES) and its adjacent anatomical structures, the gastric sling and crural diaphragm. Together these structures work in a coordinated manner to allow ingested food into the stomach while preventing reflux of gastric contents across the esophago-gastric junction (EGJ) into the esophagus. The same zone also permits retrograde passage of air and gastric contents into esophagus during belching and vomiting. The precise coordination required to execute such a complicated task is achieved by a finely-regulated high-pressure zone. This zone keeps the junction between esophagus and stomach continuously closed, but is still able to relax briefly via input from inhibitory neurons that are responsible for its innervation. Alterations of the structure and function of the EGJ and the LES may predispose to gastroesophageal reflux disease (GERD).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286675      PMCID: PMC2689423          DOI: 10.3748/wjg.14.985

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  71 in total

Review 1.  Central mechanisms of lower esophageal sphincter control.

Authors:  Pamela J Hornby; T Patrick Abrahams; Elita R Partosoedarso
Journal:  Gastroenterol Clin North Am       Date:  2002-12       Impact factor: 3.806

2.  Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention.

Authors:  W G Paterson; M A Anderson; N Anand
Journal:  Can J Physiol Pharmacol       Date:  1992-07       Impact factor: 2.273

3.  The distribution of spinal and vagal sensory neurons that innervate the esophagus of the cat.

Authors:  P I Collman; L Tremblay; N E Diamant
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

4.  Adenocarcinoma of the esophagus: role of obesity and diet.

Authors:  L M Brown; C A Swanson; G Gridley; G M Swanson; J B Schoenberg; R S Greenberg; D T Silverman; L M Pottern; R B Hayes; A G Schwartz
Journal:  J Natl Cancer Inst       Date:  1995-01-18       Impact factor: 13.506

5.  Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.

Authors:  M F Vela; R Tutuian; P O Katz; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  2003-01       Impact factor: 8.171

6.  The effect of antireflux operations on lower oesophageal sphincter tone and postprandial symptoms.

Authors:  L Lundell; J C Myers; G G Jamieson
Journal:  Scand J Gastroenterol       Date:  1993-08       Impact factor: 2.423

7.  Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs.

Authors:  J Boulant; J Fioramonti; M Dapoigny; G Bommelaer; L Bueno
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.

Authors:  Michael S Kim; Richard H Holloway; John Dent; David S Utley
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

9.  Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual.

Authors:  D A Katzka; M Sidhu; D O Castell
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

10.  The actions of baclofen on neurones and synaptic transmission in the nucleus tractus solitarii of the rat in vitro.

Authors:  P A Brooks; S R Glaum; R J Miller; K M Spyer
Journal:  J Physiol       Date:  1992-11       Impact factor: 5.182

View more
  6 in total

1.  Effect of electrical stimulation of the lower esophageal sphincter using endoscopically implanted temporary stimulation leads in patients with reflux disease.

Authors:  Rupa Banerjee; Nitesh Pratap; Rakesh Kalpala; D Nageshwar Reddy
Journal:  Surg Endosc       Date:  2013-10-30       Impact factor: 4.584

2.  Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux.

Authors:  Jerome R Lechien; Francois Bobin; Francois Mouawad; Karol Zelenik; Christian Calvo-Henriquez; Carlos M Chiesa-Estomba; Necati Enver; Andrea Nacci; Maria Rosaria Barillari; Antonio Schindler; Lise Crevier-Buchman; Stéphane Hans; Virginie Simeone; Elzbieta Wlodarczyk; Bernard Harmegnies; Marc Remacle; Alexandra Rodriguez; Didier Dequanter; Pierre Eisendrath; Giovanni Dapri; Camille Finck; Petros Karkos; Hillevi Pendleton; Tareck Ayad; Vinciane Muls; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-12       Impact factor: 2.503

3.  LEtS set the tone.

Authors:  Vikram Joshi; Arthur Beyder
Journal:  J Physiol       Date:  2022-04-30       Impact factor: 6.228

4.  Vagal sensory innervation of the gastric sling muscle and antral wall: implications for gastro-esophageal reflux disease?

Authors:  T L Powley; J M Gilbert; E A Baronowsky; C N Billingsley; F N Martin; R J Phillips
Journal:  Neurogastroenterol Motil       Date:  2012-08-27       Impact factor: 3.598

5.  Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.

Authors:  Zeljko Djakovic; Ivka Djakovic; Vedran Cesarec; Goran Madzarac; Tomislav Becejac; Goran Zukanovic; Domagoj Drmic; Lovorka Batelja; Anita Zenko Sever; Danijela Kolenc; Alen Pajtak; Nikica Knez; Mladen Japjec; Kresimir Luetic; Dinko Stancic-Rokotov; Sven Seiwerth; Predrag Sikiric
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 6.  Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update.

Authors:  Astrid Nehlig
Journal:  Nutrients       Date:  2022-01-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.